All In Biotech

Drug Trial Radar · NCT00663286

A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

Last checked: Nov 19, 2026Latest source record: Apr 22, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,399 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,399

Actual

Start

Oct 2006

Primary completion

Aug 2007

Sponsor

Lead sponsor
Dow Pharmaceutical SciencesIndustry
Sponsor type
Industry
First posted
Apr 22, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 12 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

  • IDP-110Drug

    Topical application for 12 weeks

  • ClindamycinDrug

    Topical application for 12 weeks

  • Benzoyl peroxideDrug

    Topical application for 12 weeks

  • VehicleDrug

    Topical application for 12 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in number of lesionsTime frame: 12 weeks

Locations

33 sites in 1 country. Site status is shown where the registry gives one.

  • Burke Pharmaceutical Research

    Hot Springs, Arkansas

  • The Savin Center, PC

    New Haven, Connecticut

  • Webster Dermatology, PA

    Hockessin, Delaware

  • Skin Care Research, Inc.

    Boca Raton, Florida

  • Advanced Dermatology and Cosmetic Surgery

    Clermont, Florida

  • North Florida Dermatology Associates, PA

    Jacksonville, Florida

  • Advanced Dermatology and Cosmetic Surgery

    Ormond Beach, Florida

  • Dermatology Research

    Pinellas Park, Florida

  • Florida Dermatology Institute

    West Palm Beach, Florida

  • Derm Center of Augusta

    Augusta, Georgia

  • MedaPhase Inc.

    Newnan, Georgia

  • Gwinnett Clinical Research Center, Inc.

    Snellville, Georgia

  • DuPage Medical Group

    Naperville, Illinois

  • Hudson Dermatology

    Evansville, Indiana

  • South Bend Clinic

    South Bend, Indiana

  • Dermatology Specialists Research

    Louisville, Kentucky

  • Michigan Center for Research Corp.

    Clinton Township, Michigan

  • Minnesota Clinical Study Center

    Fridley, Minnesota

  • SUNY Downstate Medical Center

    Brooklyn, New York

  • Atlantic Dermatologic Associates, LLP

    Brooklyn, New York

  • Office of Fran E. Cook-Bolden, MD

    New York, New York

  • Helendale Dermatology and Medical Spa

    Rochester, New York

  • Dermatology Associates of Rochester

    Rochester, New York

  • DermResearch Center of New York

    Stony Brook, New York

  • Central Sooner Research

    Norman, Oklahoma

  • Milton S. Hershey Medical Center

    Hershey, Pennsylvania

  • DermResearch, Inc.

    Austin, Texas

  • J & S Studies, Inc.

    Bryan, Texas

  • Thomas J. Stephens & Associates

    Carrollton, Texas

  • Dallas Associated Dermatologists

    Dallas, Texas

  • Education & Research Foundation

    Lynchburg, Virginia

  • Virginia Clinical Research, Inc

    Norfolk, Virginia

  • Madison Skin & Research, Inc.

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.